Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-7 of 7 for your search:
Drug:
mistletoe extract
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Mistletoe Extract in Early or Advanced Breast Cancer, a Randomized Feasibility Study
Phase:
Phase IV
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
WD 40
, NCT00176046
2.
Phase III Randomized Trial of Adjuvant Treatment with IFN-A vs IFN-G vs Mistletoe Extract (Iscador M) vs No Further Treatment Following Curative Resection of High-Risk Stage I/IIB Malignant Melanoma (Summary Last Modified 11/93)
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
18 to 80
Sponsor:
Protocol IDs:
EORTC-DKG-80-1
3.
Phase II Study of Supplemental Treatment With Mistletoe in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer Receiving Palliative Chemotherapy
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
TJUH-01F.45
, TJUH-2001-35, NCT00052325
4.
Phase I Study of Mistletoe Lectin (Recombinant Viscumin) in Patients With Refractory Advanced Solid Tumors
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
EORTC-16002
, NCT00006354
5.
Phase I Study of Mistletoe Lectin (Recombinant Viscumin) in Patients With Refractory Advanced Solid Tumors
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
EORTC-13001
, NCT00006477
6.
Phase I Study of Gemcitabine and Mistletoe in Patients With Advanced Solid Tumors
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCCAM, NCI, Other
Protocol IDs:
NCCAM-02-AT-260
, NCI-02-AT-0260, NCT00049608
7.
Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer
Phase:
No phase specified
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
1056757
, Mistletoe, NCT00283478
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute